Liven Pharma Limited (PSX:LIVEN)
Pakistan · Delayed Price · Currency is PKR 31.48
-0.42 (-1.32%)
At close: Oct 19, 2026
Liven Pharma Balance Sheet
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 18.25 | 7.88 | 24.96 | 0.03 | 0.03 |
Short-Term Investments | 163.3 | - | - | - | - |
Cash & Short-Term Investments | 181.55 | 7.88 | 24.96 | 0.03 | 0.03 |
Cash Growth | 2202.66% | -68.41% | 92385.38% | 0.20% | -44.73% |
Accounts Receivable | 11.12 | 9.4 | 101.02 | - | - |
Other Receivables | 0.73 | - | - | - | - |
Receivables | 11.85 | 9.4 | 101.02 | - | - |
Inventory | 92.9 | 123.32 | 123.78 | - | - |
Prepaid Expenses | 0.02 | 0.06 | 0.07 | - | - |
Other Current Assets | 6.76 | 7.28 | 10.45 | - | - |
Total Current Assets | 293.08 | 147.95 | 260.28 | 0.03 | 0.03 |
Property, Plant & Equipment | 918.16 | 666.51 | 665.55 | 131.45 | 144.55 |
Other Intangible Assets | 4.8 | 8.44 | 1.4 | - | - |
Other Long-Term Assets | - | - | - | 0.03 | 0.03 |
Total Assets | 1,216 | 822.9 | 927.23 | 131.5 | 144.6 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 25.75 | 25.45 | 14.03 | - | 0 |
Accrued Expenses | 38.06 | 21.8 | 5.4 | 0.78 | 0.92 |
Short-Term Debt | 24.4 | 25.23 | 155.16 | 237.62 | 235.35 |
Current Portion of Long-Term Debt | 2.5 | 2.5 | 0.29 | - | - |
Current Portion of Leases | 1.68 | 0.59 | 0.4 | - | - |
Other Current Liabilities | 18.89 | 14.85 | 1.2 | - | - |
Total Current Liabilities | 111.27 | 90.43 | 176.48 | 238.4 | 236.27 |
Long-Term Debt | 2.52 | 5.1 | 1.06 | - | - |
Long-Term Leases | 2.34 | 1.25 | - | - | - |
Long-Term Deferred Tax Liabilities | 114.45 | 92.27 | - | 15.72 | 18.62 |
Total Liabilities | 230.58 | 189.04 | 177.54 | 254.12 | 254.89 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 1,130 | 930.4 | 0.4 | 121.24 | 121.24 |
Retained Earnings | -333.86 | -296.54 | 159.78 | -288.3 | -283.07 |
Comprehensive Income & Other | 188.91 | - | 589.51 | 44.44 | 51.54 |
Shareholders' Equity | 985.46 | 633.86 | 749.69 | -122.62 | -110.29 |
Total Liabilities & Equity | 1,216 | 822.9 | 927.23 | 131.5 | 144.6 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 33.44 | 34.67 | 156.91 | 237.62 | 235.35 |
Net Cash (Debt) | 148.11 | -26.78 | -131.95 | -237.59 | -235.32 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | 1.33 | -0.33 | -3298.85 | -19.60 | -19.41 |
Filing Date Shares Outstanding | 113.04 | 93.04 | 12.12 | 12.12 | 12.12 |
Total Common Shares Outstanding | 113.04 | 93.04 | 12.12 | 12.12 | 12.12 |
Working Capital | 181.81 | 57.53 | 83.8 | -238.37 | -236.24 |
Book Value Per Share | 8.72 | 6.81 | 61.84 | -10.11 | -9.10 |
Tangible Book Value | 980.66 | 625.42 | 748.29 | -122.62 | -110.29 |
Tangible Book Value Per Share | 8.68 | 6.72 | 61.72 | -10.11 | -9.10 |
Land | 148.05 | 105.75 | 105.78 | 13.55 | 13.55 |
Buildings | 326.4 | 247.95 | 247.95 | 174.88 | 174.88 |
Machinery | 598.35 | 434.5 | 407.66 | 108.93 | 108.93 |